Skip to content

Clinical trials

Hemorrhagic Disorders trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Disorders Country / region: United Kingdom Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20121
20131
20142
20151
20161
20172
20183
20191
20201
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated3
Recruiting2
Active, not recruiting1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical5
Swedish Orphan Biovitrum3
Baxalta now part of Shire2
Genzyme, a Sanofi Company2
Novartis Pharmaceuticals2
Takeda2
CTI BioPharma1
Cangene Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhagic Disorders18
Hematologic Diseases17
Blood Coagulation Disorders14
Coagulation Protein Disorders12
Hemophilia A11
Genetic Diseases, Inborn10
Blood Coagulation Disorders, Inherited8
Blood Platelet Disorders5
Hemostatic Disorders5
Bone Marrow Diseases4

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.